Sodium-glucose co-transporter 1 and 2 expression in the mammary artery of patients with bypass surgery: role of the pro-inflammatory response and contribution to oxidative stress

被引：0
|
作者：
Park, S. H. [1 ]
Amissi, S. [1 ]
Algara-Suarez, P. [1 ]
Gong, D. S. [1 ]
Mroueh, A. [1 ]
Belcastro, E. [1 ]
Matsushita, K. [1 ]
Bruckert, C. [1 ]
Chaker, A. B. [1 ]
Jesel, L. [2 ]
Ohlmann, P. [2 ]
Morel, O. [2 ]
Mazzucotelli, J. P. [2 ]
Schini-Kerth, V. B. [1 ]
机构：
[1] Univ Strasbourg, INSERM UMR 1260, Regenerat Nanomed, Strasbourg, France
[2] Univ Hosp Strasbourg, Cardiol, Strasbourg, France
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3440 / 3440
页数：1
相关论文
共 50 条
  • [1] Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Regulation of Inflammatory Processes in Animal Models
    Feijoo-Bandin, Sandra
    Aragon-Herrera, Alana
    Otero-Santiago, Manuel
    Anido-Varela, Laura
    Morana-Fernandez, Sandra
    Tarazon, Estefania
    Rosello-Lleti, Esther
    Portoles, Manuel
    Gualillo, Oreste
    Gonzalez-Juanatey, Jose Ramon
    Lago, Francisca
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (10)
  • [2] The Role of Sodium-Glucose Co-transporter 2 Inhibitors in Patients With Hypomagnesemia: A Systematic Review
    Singh, Madhusudan P.
    Agrawal, Nikunj
    Agrawal, Abhimanyu
    Kushwah, Salil S.
    Krishna, Ekta
    Singh, Juhi M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [3] USE OF SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS IN PREOPERATIVE PREPARATION OF PATIENTS FOR BARIATRIC SURGERY
    Shah, P.
    Shah, S.
    OBESITY SURGERY, 2022, 32 (SUPPL 2) : 586 - 586
  • [4] Time to rethink the role of sodium-glucose co-transporter 2 inhibitors in the elderly
    Patoulias, Dimitrios
    Stavropoulos, Konstantinos
    Imprialos, Konstantinos
    Doumas, Michael
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2019, 129 (02): : 939 - 940
  • [5] Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis
    Kang, Yingxiu
    Zhan, Fenfen
    He, Minzhi
    Liu, Zhenjie
    Song, Xiaoxiao
    VASCULAR PHARMACOLOGY, 2020, 133
  • [6] Sodium-glucose co-transporter (SGLT)2 and SGLT1 renal expression in patients with type 2 diabetes
    Solini, Anna
    Rossi, Chiara
    Mazzanti, Chiara M.
    Proietti, Agnese
    Koepsell, Hermann
    Ferrannini, Ele
    DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1289 - 1294
  • [7] The Role of Sodium-Glucose Co-Transporter 2 Inhibitors in the Treatment of Type 2 Diabetes
    Whalen, Karen
    Miller, Shannon
    St Onge, Erin
    CLINICAL THERAPEUTICS, 2015, 37 (06) : 1150 - 1166
  • [8] Sodium-glucose co-transporter 2 inhibitors in patients with chronic kidney disease
    Solomon, Joshua
    Festa, Maria Carolina
    Chatzizisis, Yiannis S.
    Samanta, Ratna
    Suri, Rita S.
    Mavrakanas, Thomas A.
    PHARMACOLOGY & THERAPEUTICS, 2023, 242
  • [9] Sodium-glucose co-transporter (SGLT) and glucose transporter (GLUT) expression in the kidney of type 2 diabetic subjects
    Norton, Luke
    Shannon, Christopher E.
    Fourcaudot, Marcel
    Hu, Cheng
    Wang, Niansong
    Ren, Wei
    Song, Jun
    Abdul-Ghani, Muhammad
    DeFronzo, Ralph A.
    Ren, Jimmy
    Jia, Weiping
    DIABETES OBESITY & METABOLISM, 2017, 19 (09): : 1322 - 1326
  • [10] Recent Progress and Perspectives in Sodium-Glucose Co-transporter 1/2 Inhibitors
    Demirkiran, Cahit
    Demiryurek, Seniz
    Demiryurek, Abdullah Tuncay
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2025, 25 (05) : 354 - 364
12345